RetractedArticleDiscover oncology2021

IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma.

Keita Sasa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.